Delayed-type reactivity to calcipotriol without cross-sensitization to tacalcitol.
Zollner
T M
TM
Department of Dermatology, University of Frankfurt Medical School, Germany.
Ochsendorf
F R
FR
Hensel
O
O
Thaci
D
D
Diehl
S
S
Kalveram
C M
CM
Boehncke
W H
WH
Wolter
M
M
Kaufmann
R
R
D000287:Administration, Topical; D002117:Calcitriol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003429:Cross Reactions / Q000276:immunology; D017449:Dermatitis, Allergic Contact / Q000209:etiology* / Q000473:pathology; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004100:Dihydroxycholecalciferols / Q000627:therapeutic use*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D011565:Psoriasis / Q000188:drug therapy
D003879:Dermatologic Agents; D004100:Dihydroxycholecalciferols; C055085:calcipotriene; C023850:1 alpha,24-dihydroxyvitamin D3; D002117:Calcitriol